CIK 0000715446
- Non-accelerated filer
- Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 112622630
- Phone
- +1 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 10,000 shares at $0.90 ($9,000)
- 4 Open-market buy President & CEO bought 10,000 shares at an average $0.88 ($8,797)
- 4 Open-market buy Director bought 10,000 shares at an average $0.88 ($8,776)
- 4 Option exercise President and CEO acquired 5,995 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion VP, Finance & CFO acquired 2,000 shares (option exercise)
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 210,000 shares at $3.10 ($651,000)
- 4 Open-market buy Director bought 4,500 shares at $3.26 ($14,670)
- 4 Open-market buy Director bought 400 shares at $3.16 ($1,264)
- 4 Open-market buy Director bought 400 shares at an average $3.52 ($1,408)
Page 11 of 24 · 471 filings